Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults. [PDF]
Adv TherRamapalaniappan A +6 more
europepmc +1 more source
Investigating the genetic potential of Ashwagandha (Withania somnifera L. Dunal) germplasm through SCoT and EST-SSR molecular markers. [PDF]
Sci RepMandliya T, Haq SU, Jain R, Jain D.
europepmc +1 more source
System-Level, Molecular and Cellular Mechanisms of Selected Plant Adaptogens-A Review. [PDF]
NutrientsSuch S +3 more
europepmc +1 more source
Ayurveda Treatments for Insomnia: A Narrative Review. [PDF]
J Clin MedVendrame M, Chai V.
europepmc +1 more source
Comprehensive safety evaluation of <i>Withania somnifera</i> (Ashwagandha): an AI-driven meta-analysis and quantitative structure-activity relationship based toxicity assessment. [PDF]
Front NutrRonen Y +5 more
europepmc +1 more source
Evaluating the Safety of Ashwagandha as a Food Additive: A Focus on Reproductive, Thyroid, and Immune System Effects. [PDF]
Phytother ResLi L +7 more
europepmc +1 more source
Jidongwangia sp. JTT04 as a novel bioinoculant: promoting growth and modulating the metabolic profile of Ashwagandha (Withania somnifera (L.) Dunal). [PDF]
BMC Plant BiolMohammed AE +7 more
europepmc +1 more source
Curcumin, Coenzyme-Q10, and Bioactive Compounds in Ashwagandha Extract: Multi-Targeting Potential of Co-Administered Natural Health Compounds as Therapeutic and Preventative Interventions in Alzheimer's and Parkinson's Disease Models. [PDF]
NutrientsDube K, Stoinescu A, Pandey S.
europepmc +1 more source
<i>Rhodiola rosea</i>, <i>Ginkgo biloba</i>, and Ashwagandha as novel antidepressant supplements: converging monoaminergic, neurotrophic, anti-inflammatory, and brain health pathways in depressive disorders. [PDF]
Front NutrLi X +7 more
europepmc +1 more source